Results 161 to 170 of about 2,312,469 (251)

Mucosal‐Associated Invariant T Cells in Health and Disease

MedComm, Volume 7, Issue 10, October 2026.
The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao, Feng‐Mi Ou, Dan Liang, Yang Gao, Qing‐Qing Li, Yi‐Qun Kuang   +5 more
wiley   +1 more source

Ultrasound biomicroscopic imaging in intermediate uveitis

, 1998
Background—Clinical examination of the region of the eye mainly aVected in patients with intermediate uveitis is diY-cult and often hampered by media opaci-ties.
Georg Häring, Bernhard Nölle, Burkhard Wiechens   +2 more
core  

New Treatments in Noninfectious Uveitis

, 2020
Miserocchi E, Pontikaki I, Modorati G, et al: Rituximab for uveitis. Ophthalmology 2011;118: 223–224. Miserocchi E, Pontikaki I, Modorati G, et al: AntiCD20 monoclonal antibody (rituximab) treatment for inflammatory ocular ...
Tomkins-Netzer, O, Taylor, SR, Lightman, SL   +2 more
core  

INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol

BJU International, Volume 138, Issue 4, Page 607-619, October 2026.
Background High‐risk non‐muscle‐invasive bladder cancer (HRNMIBC) has a variable prognosis, managed predominantly by local surgical resection and intravesical Bacillus Calmette–Guérin (BCG), or radical cystectomy (RC). Current treatments are poorly tolerated, have supply limitations and often fail to control the disease.
Ruby Lister‐Whelan, Ethan Senior, Jessica Kendall, Jamie B. Oughton, Fiona Collinson, Jon Griffin, Rachel Hubbard, Steven Kennish, Aidan Noon, Derek J. Rosario, Irbaz B. Riaz, Julie Telliez, James W. F. Catto, Syed A. Hussain   +13 more
wiley   +1 more source

Commentary: Macular vessel densities in non-invasive optical coherence tomography angiography: Challenges in intermediate uveitis. [PDF]

Indian J Ophthalmol, 2023
Das D, Bhattacharjee H, Mishra S, Mahapatra M.   +3 more
europepmc   +1 more source

Building an Interleukin‐10‐Producing Identity: How B Cells Acquire Interleukin‐10 Competence and How Plasma Cell Differentiation Consolidates This Program

Immunological Reviews, Volume 343, Issue 1, October 2026.
ABSTRACT Interleukin (IL)‐10‐producing B cells represent an archetype for the regulatory functions of B cells. Here, we review the cell‐surface receptors and transcriptional regulators that control IL‐10 expression in B cells and enable their regulatory function in vivo.
Bui Thi Cuc, Yanli Tong, Zhiguo Wu, Daniel Alvarez‐Simon, Simon Fillatreau   +4 more
wiley   +1 more source

Optical coherence tomography angiography in intermediate uveitis-related cystoid macular edema. [PDF]

Med Hypothesis Discov Innov Ophthalmol, 2022
Alizadeh Ghavidel L, Mousavi F, Hashemi HS, Bagheri M.   +3 more
europepmc   +1 more source

Causes of uveitis in children without juvenile idiopathic arthritis

, 2015
Stephanie B Engelhard, Asima Bajwa, Ashvini K ReddyDepartment of Ophthalmology, University of Virginia, Charlottesville, VA, USABackground: The purpose of this study was to report the demographics, disease characteristics, treatments, and visual outcomes
Reddy AK, Bajwa A, Engelhard SB
core  

ACC311A: Intermediate Accounting I

, 2011
CODE: ACC311A UNIT: INTERMEDIATE ACCOUNTING ...
Daystar University
core  

Intermediate uveitis: Etiologies and outcomes in a tertiary referral hospital in KSA. [PDF]

Saudi J Ophthalmol, 2021
Al-Hujaili H, AlAbduljabbar K, AlAkeely A, Al-Dhibi HA.   +3 more
europepmc   +1 more source